The EGFR mutation rate in tumor tissues was 32.26% (10/31), including 7 cases of deletion mutation in exon 19 (exon 19 Del) and 3 cases of L858R substitute mutation in exon 21 (exon 21 L858R). The gene discussed is EGFR; the disease is neoplasm.